The DOI matches its Crossref record.
Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology
Abstract
The ability to select a sensitive patient population may be crucial for the development of a targeted therapy. Identifying such a population with an acceptable level of confidence may lead to an inflation in development time and cost. We present an approach that allows to decrease these costs and to increase the reliability of the population selection. It is based on an actual adaptive phase II/III design and uses Bayesian decision tools to select the population of interest at an interim analysis. The primary endpoint is assumed to be the time to some event like e.g. progression. It is shown that the use of appropriately stratified logrank tests in the adaptive test procedure guarantees overall type I error control also when using information on patients that are censored at the adaptive interim analysis. The use of Bayesian decision tools for the population selection decision making is discussed. Simulations are presented to illustrate the operating characteristics of the study design relative to a more traditional development approach. Estimation of treatment effects is considered as well. Copyright © 2009 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Adaptive designs for confirmatory clinical trials
Bretz, F., Koenig, F., Brannath, W., Glimm, E., & Posch, M. (2009) · Statistics in Medicine · doi:10.1002/sim.3538 · Cited by 266
Self-citationDimairo, M., Pallmann, P., Wason, J., Todd, S., Jaki, T., Julious, S. A., Mander, A. P., Weir, C. J., Koenig, F., Walton, M. K., et al. (2020) · Trials · doi:10.1186/s13063-020-04334-x · Cited by 58
General guidance on exploratory and confirmatory subgroup analysis in late-stage clinical trials
Dmitrienko, A., Muysers, C., Fritsch, A., & Lipkovich, I. (2016) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2015.1092033 · Cited by 51
Metadata
- Authors
- Brannath, W., Zuber, E., Branson, M., Bretz, F., Gallo, P., Posch, M., & Racine‐Poon, A.
- Venue
- Statistics in Medicine
- Publisher
- Wiley
- Published
- 2009-03-05
- Volume
- 28
- Issue
- 10
- Pages
- 1445-1463
- ISSN
- 0277-6715 (ISSN-L)
- 1097-0258
- OpenAlex
- W2115840402
- Cited by
- 200
- References
- 0
- FWCI
- 9.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.